Lipid-Lowering: Reduce Blood Fats and Protect the Heart
Lipid-lowering refers to measures that reduce elevated blood fat levels. It protects against cardiovascular disease through lifestyle changes and medications such as statins.
Things worth knowing about "Lipid-lowering"
Lipid-lowering refers to measures that reduce elevated blood fat levels. It protects against cardiovascular disease through lifestyle changes and medications such as statins.
What Is Lipid-Lowering?
Lipid-lowering refers to all medical and lifestyle-based strategies aimed at reducing elevated blood fat levels. The most clinically relevant lipids include LDL cholesterol (often called bad cholesterol), triglycerides, and total cholesterol. Persistently elevated blood lipid levels significantly increase the risk of arteriosclerosis, heart attack, and stroke.
Causes of Elevated Blood Lipid Levels
Elevated blood lipid levels (medically known as hyperlipidemia or dyslipidemia) can have several causes:
- Dietary factors: Excessive consumption of saturated fats and trans fats
- Genetic factors: Familial hypercholesterolemia, an inherited condition
- Secondary causes: Diabetes mellitus, hypothyroidism, kidney disease, certain medications
- Lifestyle factors: Physical inactivity, obesity, alcohol consumption, smoking
Goals of Lipid-Lowering Therapy
The primary goal of lipid-lowering therapy is to reduce cardiovascular risk. Target values depend on the individual risk profile of the patient. According to European guidelines, LDL cholesterol in high-risk patients should be reduced to below 55 mg/dl.
Non-Pharmacological Measures
Physicians typically recommend lifestyle modifications as a first step:
- Dietary changes: Reducing saturated fat intake, increasing fiber, plant sterols, and unsaturated fatty acids (e.g., olive oil, fatty fish)
- Regular physical activity: At least 150 minutes of moderate exercise per week
- Weight loss in overweight individuals
- Smoking cessation and limiting alcohol intake
Pharmacological Therapy
When lifestyle changes are insufficient, lipid-lowering medications are prescribed:
Statins
Statins (e.g., atorvastatin, simvastatin, rosuvastatin) are the most widely used lipid-lowering drugs. They inhibit the enzyme HMG-CoA reductase, which is responsible for cholesterol synthesis in the liver, thereby effectively lowering LDL cholesterol levels.
Ezetimibe
Ezetimibe inhibits cholesterol absorption in the small intestine and is often used in combination with statins to achieve additional LDL reduction.
PCSK9 Inhibitors
PCSK9 inhibitors (e.g., evolocumab, alirocumab) are modern antibody-based therapies that prevent the degradation of LDL receptors, leading to a substantial reduction in LDL levels. They are mainly used in high-risk patients or those intolerant to statins.
Fibrates and Niacin
Fibrates (e.g., fenofibrate) primarily lower triglyceride levels and are used when triglycerides are markedly elevated. Niacin (vitamin B3 at high doses) can also improve lipid profiles but is used less frequently due to its side effect profile.
Omega-3 Fatty Acids
High-dose omega-3 fatty acids (EPA/DHA) can reduce triglyceride levels and are approved as add-on therapy in hypertriglyceridemia.
Side Effects of Lipid-Lowering Medications
Lipid-lowering medications are generally well tolerated. Possible side effects include:
- Statins: Muscle pain (myopathy), rarely elevated liver enzymes, increased blood glucose
- Ezetimibe: Gastrointestinal complaints, rarely elevated liver enzymes
- PCSK9 inhibitors: Injection site reactions, cold-like symptoms
- Fibrates: Gastrointestinal issues, rarely muscle problems (especially in combination with statins)
Monitoring and Follow-Up
Regular blood tests are performed to monitor lipid-lowering therapy, including a lipid panel (LDL, HDL, triglycerides, total cholesterol), liver enzymes, and, for statins, occasionally creatine kinase (CK) levels. Target values are set individually based on cardiovascular risk.
References
- Mach F et al. - 2019 ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal, 2020.
- Grundy SM et al. - 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. Journal of the American College of Cardiology, 2019.
- World Health Organization (WHO) - Cardiovascular diseases: Key facts. WHO, 2021. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.